Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L9LS monoclonal antibody for malaria prevention in Kenyan children
PACTR202205899641128Phase 2Recruiting
- Sponsor
- National Institutes of Health
- Start
- Aug 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of L9LS, sponsored by National Institutes of Health. Started Aug 2022; status: recruiting.
02
Drugs
L9LS
Beyond the preview
Go deeper on PACTR202205899641128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202205899641128.